189 related articles for article (PubMed ID: 24748476)
1. Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.
Naka K K; Vezyraki P; Kalaitzakis A; Zerikiotis S; Michalis L; Angelidis C
Cell Stress Chaperones; 2014 Nov; 19(6):853-64. PubMed ID: 24748476
[TBL] [Abstract][Full Text] [Related]
2. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
[TBL] [Abstract][Full Text] [Related]
3. The increased expression of the inducible Hsp70 (HSP70A1A) in serum of patients with heart failure and its protective effect against the cardiotoxic agent doxorubicin.
Zerikiotis S; Angelidis C; Dhima I; Naka KK; Kasioumi P; Kalfakakou V; Peschos D; Vezyraki P
Mol Cell Biochem; 2019 May; 455(1-2):41-59. PubMed ID: 30390173
[TBL] [Abstract][Full Text] [Related]
4. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.
Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y
PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice.
Sun A; Zou Y; Wang P; Xu D; Gong H; Wang S; Qin Y; Zhang P; Chen Y; Harada M; Isse T; Kawamoto T; Fan H; Yang P; Akazawa H; Nagai T; Takano H; Ping P; Komuro I; Ge J
J Am Heart Assoc; 2014 Sep; 3(5):e000779. PubMed ID: 25237043
[TBL] [Abstract][Full Text] [Related]
6. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways.
Gao G; Jiang S; Ge L; Zhang S; Zhai C; Chen W; Sui S
J Cardiovasc Pharmacol; 2019 Apr; 73(4):223-231. PubMed ID: 30540688
[TBL] [Abstract][Full Text] [Related]
8. [Overexpression of heat shock protein 27 reduces mortality and attenuates cardiac dysfunction induced by doxorubicin in a transgenic mouse model].
Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):595-8. PubMed ID: 17961420
[TBL] [Abstract][Full Text] [Related]
9. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
11. Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein.
Wang L; Zhang TP; Zhang Y; Bi HL; Guan XM; Wang HX; Wang X; Du J; Xia YL; Li HH
Sci Rep; 2016 Jun; 6():28399. PubMed ID: 27323684
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J; De Rosa S; Tammè L; Iaconetti C; Sorrentino S; Polimeni A; Mignogna C; Amorosi A; Spaccarotella C; Yasuda M; Indolfi C
Cardiovasc Diabetol; 2020 May; 19(1):66. PubMed ID: 32414364
[TBL] [Abstract][Full Text] [Related]
13. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
Zhu W; Reuter S; Field LJ
Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
[TBL] [Abstract][Full Text] [Related]
14. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
Zhu W; Zhang W; Shou W; Field LJ
Cardiovasc Res; 2014 Jul; 103(1):81-9. PubMed ID: 24812279
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
16. Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin-Induced Heart Failure Through Resolution of Toll-Like Receptor 2-Mediated Myocardial Inflammation.
Liu P; Bao HY; Jin CC; Zhou JC; Hua F; Li K; Lv XX; Cui B; Hu ZW; Zhang XW
J Am Heart Assoc; 2019 Oct; 8(20):e012338. PubMed ID: 31576776
[TBL] [Abstract][Full Text] [Related]
17. [Heat shock protein 27 attenuated doxorubicin-induced myocardial damage by reducing cardiomyocyte apoptosis, mitochondria damage and protein carbonylation].
Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1021-6. PubMed ID: 19102918
[TBL] [Abstract][Full Text] [Related]
18. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
20. Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice.
Vedam K; Nishijima Y; Druhan LJ; Khan M; Moldovan NI; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1832-41. PubMed ID: 20363884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
